Opinion|Videos|May 23, 2024
Impact of Geriatric Syndrome in Older Adults with T2D
Key opinion leaders in the management of diabetes define and discuss the impact and complexities of geriatric syndromes in older adults with T2D. They shed light on challenges like cognitive impairment, urinary incontinence, and neuropathy, offering insights into effective diabetes management strategies for this demographic.
Advertisement
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
Advertisement
Advertisement
Trending on Patient Care Online
1
CagriSema Cuts Weight Up to 27% Across Menopause Stages: TMS 2026
2
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
3
New Study Finds Low Initiation, Persistence With Menopause Hormone Therapy
4
Menopause Hormone Therapy Gaps Raise Questions for Primary Care
5